Gujarat Themis Biosyn implements new business model

26 Sep 2019 Evaluate

Gujarat Themis Biosyn has implemented its new business model of manufacturing and supply of pharmaceutical products to various parties.

Gujarat Themis Biosyn is a biotech and synthetic product manufacturing company. The company’s principal activity is to manufacture and distributes pharmaceuticals bulk drugs called rifampicin produced by fermentation process. The company's products include preparations of active pharmaceutical ingredient rifampicin and lovastatin. The company exports its products to Europe and the United States. 

Guj. Themis Biosyn Share Price

315.35 -19.40 (-5.80%)
21-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1612.55
Dr. Reddys Lab 1155.50
Cipla 1369.55
Zydus Lifesciences 876.10
Lupin 2139.40
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×